BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 38256274)

  • 1. An Overview of Advances in Rare Cancer Diagnosis and Treatment.
    Christyani G; Carswell M; Qin S; Kim W
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer.
    Li J; Li L; You P; Wei Y; Xu B
    Semin Cancer Biol; 2023 Jun; 91():35-49. PubMed ID: 36868394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence-based multi-omics analysis fuels cancer precision medicine.
    He X; Liu X; Zuo F; Shi H; Jing J
    Semin Cancer Biol; 2023 Jan; 88():187-200. PubMed ID: 36596352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial Intelligence for Precision Oncology.
    Bhalla S; Laganà A
    Adv Exp Med Biol; 2022; 1361():249-268. PubMed ID: 35230693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application and prospect of artificial intelligence in cancer diagnosis and treatment].
    Shen TL; Fu XL
    Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):881-884. PubMed ID: 30605975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment.
    Zhang C; Xu J; Tang R; Yang J; Wang W; Yu X; Shi S
    J Hematol Oncol; 2023 Nov; 16(1):114. PubMed ID: 38012673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the application of computational pathology in diagnosis, immunomicroenvironment recognition, and immunotherapy evaluation of breast cancer: a narrative review.
    Luo J; Li X; Wei KL; Chen G; Xiong DD
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12535-12542. PubMed ID: 37389595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
    Kashyap K; Siddiqi MI
    Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial Intelligence and Machine Learning in Cancer Research: A Systematic and Thematic Analysis of the Top 100 Cited Articles Indexed in Scopus Database.
    Musa IH; Afolabi LO; Zamit I; Musa TH; Musa HH; Tassang A; Akintunde TY; Li W
    Cancer Control; 2022; 29():10732748221095946. PubMed ID: 35688650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence.
    Xu Y; Su GH; Ma D; Xiao Y; Shao ZM; Jiang YZ
    Signal Transduct Target Ther; 2021 Aug; 6(1):312. PubMed ID: 34417437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial Intelligence in Pathomics and Genomics of Renal Cell Carcinoma.
    Knudsen JE; Rich JM; Ma R
    Urol Clin North Am; 2024 Feb; 51(1):47-62. PubMed ID: 37945102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging roles of artificial intelligence in cancer drug development and precision therapy.
    Liang G; Fan W; Luo H; Zhu X
    Biomed Pharmacother; 2020 Aug; 128():110255. PubMed ID: 32446113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial intelligence in liver cancers: Decoding the impact of machine learning models in clinical diagnosis of primary liver cancers and liver cancer metastases.
    Bakrania A; Joshi N; Zhao X; Zheng G; Bhat M
    Pharmacol Res; 2023 Mar; 189():106706. PubMed ID: 36813095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial intelligence for prediction of response to cancer immunotherapy.
    Yang Y; Zhao Y; Liu X; Huang J
    Semin Cancer Biol; 2022 Dec; 87():137-147. PubMed ID: 36372326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial intelligence in cancer research, diagnosis and therapy.
    Elemento O; Leslie C; Lundin J; Tourassi G
    Nat Rev Cancer; 2021 Dec; 21(12):747-752. PubMed ID: 34535775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of artificial intelligence multiomics in precision oncology.
    Srivastava R
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):503-510. PubMed ID: 35796775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of Radiological Treatment Response Assessments for Cancer Immunotherapy: From iRECIST to Radiomics and Artificial Intelligence.
    Kim N; Lee ES; Won SE; Yang M; Lee AJ; Shin Y; Ko Y; Pyo J; Park HJ; Kim KW
    Korean J Radiol; 2022 Nov; 23(11):1089-1101. PubMed ID: 36098343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in the application of artificial intelligence in cancer diagnosis and treatment].
    Liu WD; Zhou HB; Hu HP
    Zhonghua Gan Zang Bing Za Zhi; 2018 Aug; 26(8):633-636. PubMed ID: 30317800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Big Data, Machine Learning, and Artificial Intelligence to Advance Cancer Care: Opportunities and Challenges.
    Charalambous A; Dodlek N
    Semin Oncol Nurs; 2023 Jun; 39(3):151429. PubMed ID: 37085405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial design in the era of precision medicine.
    Fountzilas E; Tsimberidou AM; Vo HH; Kurzrock R
    Genome Med; 2022 Aug; 14(1):101. PubMed ID: 36045401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.